Guideline changes offer opportunity to demand better care for people with heart failure

News & Events

15 June 2022

Over 10 million people in Europe are living with heart failure, but 28% of them do not receive the best-practice care recommended by clinical guidelines. This is an unacceptable care gap, but one that we can hope to close.

HFPN’s new report, From guidelines to action: Opportunities for change following the 2021 ESC guidelines, is part of our efforts to close this gap. It marks the start of our exciting new work aiming to translate international heart failure guidelines into concrete action at national and local levels.

HFPN supports the heart failure community in its efforts to drive actionable change and make a real impact on the care and treatment of people with heart failure. We see the 2021 European Society of Cardiology (ESC) guidelines as catalyst for this action.

Among the changes in the new guidelines, we are excited to see a renewed focus on the importance of person-centred care and self-management, recognition of the potential benefits of telemonitoring and the introduction of dedicated recommendations for the management of heart failure alongside other commonly occurring conditions.

Our report lays out the potential implications of these changes for people with heart failure and wider society. We look at the barriers to and opportunities for translating the guidelines into action, and  provide four ‘policy hooks’ that the heart failure community can use to engage policymakers:

We hope that this work will equip advocates with the tools to communicate effectively with decision-makers, and will help maximise the opportunities that the guidelines present for improving diagnosis, treatment and quality of life for people living with heart failure.

View the project


More from News & Events

9 things we learnt from the Heart Failure Policy Summit 2022
9 things we learnt from the Heart Failure Policy Summit 2022...
13 January 2023
Last year's Summit brought together experts from the heart failure and wider health advocacy communities. Here, we reflect on some learning points....
Read article
Innovation in heart failure: how can we ensure early diagnos
Innovation in heart failure: how can we ensure early diagnos...
08 December 2022
Our ‘Innovation in heart failure: early diagnosis in community settings’ report outlines the urgent need to boost timely diagnosis and presents a variety of promising initiativ...
Read article
The Heart Failure Policy Network is an independent, multidisciplinary platform made possible with financial support from AstraZeneca, CSL Vifor, Boehringer Ingelheim and Roche Diagnostics. The content produced by the Network is not biased toward any specific treatment or therapy. All outputs are guided and endorsed by the Network’s members. All members provide their time for free. The Network is hosted by The Health Policy Partnership .